On the afternoon of October 15, the special case study team of the “Research Center for Excellent Practice Knowledge in the Technology Industry (preparation)” of Shanghai International School of Chief Technology Officer (hereinafter referred to as "CTO School") led by Professor Wang Zhenyuan visited and surveyed Shanghai Symray Biopharma Co., Ltd. (hereinafter referred to as “Symray Biopharma”), the second stop of CTO School's biomedical enterprise partners.
Wang Jianrong and Chen Zhong, Assistant Professors of Asia Europe Business School of East China Normal University, and Peng Yuxin, Director of Marketing Operation Department of CTO School, attended the activity. Zhao Wenxiang, General Manager of Symray Biopharma, and Li Haifeng, Director of Intellectual Property Management warmly received the case team, and the two sides carried out in-depth negotiations on the case research and development, pain points of enterprise management and other issues. At the meeting, General Manager Zhao Wenxiang first introduced the entrepreneurial history, research and development projects and operation mode of Symray Biopharma. The follow-up special research case team would further connect with Symray Biopharma starting from how the technical executives made key decisions, when they carried out strategic upgrading and other aspects, further form solutions for the management system and talent training and carry out in-depth study of enterprise cooperation cases according to the actual situation of the company.